News

Gene TherapiesR&D project spotlight: Towards continuous manufacturing for high-dose, cost-efficient rAAV therapies
Filter:AllPress ReleaseCell TherapiesGene TherapiesDigital and AutomationSpin-outs, Start-ups, Sector investmentManufacturingRegulatory affairsSkills and Training
Year:All2025202420232022 →
The case for collaboration: Why going it alone is no longer an option in advanced therapy developmentThe case for collaboration: Why going it alone is no longer an option in advanced therapy developmentRegulatory Round-up - August 2025Regulatory Round-up - August 2025R&D project spotlight: Developing a smart bioprocessing platform integrating real-time process monitoring and advanced process control for autologous cell therapyR&D project spotlight: Developing a smart bioprocessing platform integrating real-time process monitoring and advanced process control for autologous cell therapyRegulatory Round-up - July 2025Regulatory Round-up - July 2025MHRA introduces regulations that allow decentralised manufacturing of therapiesMHRA introduces regulations that allow decentralised manufacturing of therapiesCell and Gene Therapy Catapult appoints Dr Jim Faulkner as new ChairCell and Gene Therapy Catapult appoints Dr Jim Faulkner as new ChairCell and Gene Therapy Catapult appoints Dr Ed Samuel as Chief Operating OfficerCell and Gene Therapy Catapult appoints Dr Ed Samuel as Chief Operating OfficerSpliceor receives investment from the Cell and Gene Therapy Catapult as part of the Cross-Catapult Investment PilotSpliceor receives investment from the Cell and Gene Therapy Catapult as part of the Cross-Catapult Investment PilotCGT Catapult response to publication of the Life Sciences Sector PlanCGT Catapult response to publication of the Life Sciences Sector PlanCellular Origins, Cell and Gene Therapy Catapult and Resolution Therapeutics form consortium to deliver fully automated robotics CGT manufacturing platformCellular Origins, Cell and Gene Therapy Catapult and Resolution Therapeutics form consortium to deliver fully automated robotics CGT manufacturing platformRegulatory Round-up - June 2025Regulatory Round-up - June 2025From nascent to mainstream: Overcoming barriers in iPSC therapy developmentFrom nascent to mainstream: Overcoming barriers in iPSC therapy development